On the other hand, depletion of CD8+ T cells in the preventive setting protects against NASH-HCC by inhibiting aberrant activation of CD8+PD-1+ T cells and consequent inflammation, fibrosis, and tumorigenesis.3 This evidence concerns the gene PDCD1 and metabolic dysfunction-associated steatohepatitis.